Literature DB >> 26480930

Long-Term Natural History of Adult Wolff-Parkinson-White Syndrome Patients Treated With and Without Catheter Ablation.

T Jared Bunch1, Heidi T May2, Tami L Bair2, Jeffrey L Anderson2, Brian G Crandall2, Michael J Cutler2, Victoria Jacobs2, Charles Mallender2, Joseph B Muhlestein2, Jeffrey S Osborn2, J Peter Weiss2, John D Day2.   

Abstract

BACKGROUND: There are a paucity of data about the long-term natural history of adult Wolff-Parkinson-White syndrome (WPW) patients in regard to risk of mortality and atrial fibrillation. We sought to describe the long-term outcomes of WPW patients and ascertain the impact of ablation on the natural history. METHODS AND
RESULTS: Three groups of patients were studied: 2 WPW populations (ablation: 872, no ablation: 1461) and a 1:5 control population (n=11 175). Long-term mortality and atrial fibrillation rates were determined. The average follow-up for the WPW group was 7.9±5.9 (median: 6.9) years and was similar between the ablation and nonablation groups. Death rates were similar between the WPW group versus the control group (hazard ratio, 0.96; 95% confidence interval, 0.83-1.11; P=0.56). Nonablated WPW patients had a higher long-term death risk compared with ablated WPW patients (hazard ratio, 2.10; 95% confidence interval: 1.50-20.93; P<0.0001). Incident atrial fibrillation risk was higher in the WPW group compared with the control population (hazard ratio, 1.55; 95% confidence interval, 1.29-1.87; P<0.0001). Nonablated WPW patients had lower risk than ablated patients (hazard ratio, 0.39; 95% confidence interval, 0.28-0.53; P<0.0001).
CONCLUSIONS: Long-term mortality rates in WPW patients are low and similar to an age-matched and gender-matched control population. WPW patients that underwent the multifactorial process of ablation had a lower mortality compared to nonablated WPW patients. Atrial fibrillation rates are high long-term, and ablation does not reduce this risk.
© 2015 American Heart Association, Inc.

Entities:  

Keywords:  Wolff-Parkinson-White syndrome; adult; atrial fibrillation; catheter ablation; mortality

Mesh:

Year:  2015        PMID: 26480930     DOI: 10.1161/CIRCEP.115.003013

Source DB:  PubMed          Journal:  Circ Arrhythm Electrophysiol        ISSN: 1941-3084


  10 in total

1.  Accessory pathway location affects brain natriuretic peptide level in patients with Wolff-Parkinson-White syndrome.

Authors:  Yosuke Nakatani; Koji Kumagai; Shigeto Naito; Kohki Nakamura; Kentaro Minami; Masahiro Nakano; Takehito Sasaki; Koichiro Kinugawa; Shigeru Oshima
Journal:  J Interv Card Electrophysiol       Date:  2016-11-04       Impact factor: 1.900

2.  Reversal of systolic dysfunction in noncompaction and Wolff-Parkinson-White syndrome after accessory pathway ablation.

Authors:  Katrin Rezkalla; Edmund Gatterer; Matthias Hasun; Johannes Huber; Claudia Stöllberger; Franz Weidinger
Journal:  J Cardiol Cases       Date:  2021-06-13

3.  For Whom the Bell Tolls : Refining Risk Assessment for Sudden Cardiac Death.

Authors:  Ivaylo Tonchev; David Luria; David Orenstein; Chaim Lotan; Yitschak Biton
Journal:  Curr Cardiol Rep       Date:  2019-08-02       Impact factor: 2.931

4.  European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on risk assessment in cardiac arrhythmias: use the right tool for the right outcome, in the right population.

Authors:  Jens Cosedis Nielsen; Yenn-Jiang Lin; Marcio Jansen de Oliveira Figueiredo; Alireza Sepehri Shamloo; Alberto Alfie; Serge Boveda; Nikolaos Dagres; Dario Di Toro; Lee L Eckhardt; Kenneth Ellenbogen; Carina Hardy; Takanori Ikeda; Aparna Jaswal; Elizabeth Kaufman; Andrew Krahn; Kengo Kusano; Valentina Kutyifa; Han S Lim; Gregory Y H Lip; Santiago Nava-Townsend; Hui-Nam Pak; Gerardo Rodríguez Diez; William Sauer; Anil Saxena; Jesper Hastrup Svendsen; Diego Vanegas; Marmar Vaseghi; Arthur Wilde; T Jared Bunch; Alfred E Buxton; Gonzalo Calvimontes; Tze-Fan Chao; Lars Eckardt; Heidi Estner; Anne M Gillis; Rodrigo Isa; Josef Kautzner; Philippe Maury; Joshua D Moss; Gi-Byung Nam; Brian Olshansky; Luis Fernando Pava Molano; Mauricio Pimentel; Mukund Prabhu; Wendy S Tzou; Philipp Sommer; Janice Swampillai; Alejandro Vidal; Thomas Deneke; Gerhard Hindricks; Christophe Leclercq
Journal:  Europace       Date:  2020-08-01       Impact factor: 5.214

5.  Asymptomatic Ventricular Pre-excitation: Between Sudden Cardiac Death and Catheter Ablation.

Authors:  Josep Brugada; Roberto Keegan
Journal:  Arrhythm Electrophysiol Rev       Date:  2018-03

6.  Wolff-Parkinson-White syndrome: De novo variants and evidence for mutational burden in genes associated with atrial fibrillation.

Authors:  Zeynep H Coban-Akdemir; Wu-Lin Charng; Mahshid Azamian; Ingrid S Paine; Jaya Punetha; Christopher M Grochowski; Tomasz Gambin; Santiago O Valdes; Bryan Cannon; Gladys Zapata; Patricia P Hernandez; Shalini Jhangiani; Harsha Doddapaneni; Jianhong Hu; Fatima Boricha; Donna M Muzny; Eric Boerwinkle; Yaping Yang; Richard A Gibbs; Jennifer E Posey; Xander H T Wehrens; John W Belmont; Jeffrey J Kim; Christina Y Miyake; James R Lupski; Seema R Lalani
Journal:  Am J Med Genet A       Date:  2020-03-31       Impact factor: 2.802

7.  Assessment of the causal relevance of ECG parameters for risk of atrial fibrillation: A mendelian randomisation study.

Authors:  Parag Ravindra Gajendragadkar; Adam Von Ende; Maysson Ibrahim; Elsa Valdes-Marquez; Christian Fielder Camm; Federico Murgia; Alexander Stiby; Barbara Casadei; Jemma C Hopewell
Journal:  PLoS Med       Date:  2021-05-13       Impact factor: 11.069

8.  Precipitation of de novo atrial fibrillation during Shockwave Intravascular Lithotripsy® after pacing capture during the treatment of proximal right coronary artery disease: a case report.

Authors:  Elizabeth Curtis; Ali Khan; Seif El-Jack; Tim Glenie
Journal:  Eur Heart J Case Rep       Date:  2019-09-27

9.  Use of general anesthesia to suppress incessant atrial fibrillation in a patient undergoing ablation for supraventricular tachycardia.

Authors:  Moussa Saleh; Gourg Atteya; Jonathan Willner; Roy M John
Journal:  HeartRhythm Case Rep       Date:  2020-11-19

10.  Influence of advancing age on clinical presentation, treatment efficacy and safety, and long-term outcome of pre-excitation syndromes: a retrospective cohort study of 961 patients included over a 25-year period.

Authors:  Béatrice Brembilla-Perrot; Arnaud Olivier; Jean-Marc Sellal; Vladimir Manenti; Alice Brembilla; Thibaut Villemin; Philippe Admant; Daniel Beurrier; Erwan Bozec; Nicolas Girerd
Journal:  BMJ Open       Date:  2016-05-17       Impact factor: 2.692

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.